Triosephosphate Isomerase Level in Relation to Rheumatoid Aerthritis Activity and Structural Damage

NCT07105566 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 70

Last updated 2025-08-06

No results posted yet for this study

Summary

1. Assess the serum level of TPI in patients with RA compared to healthy controls.
2. Correlate serum level of TPI and disease activity.
3. Correlation of serum TPI level with US7 damage index

Conditions

Interventions

DIAGNOSTIC_TEST

serum TPI

serum TPI level

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Principal Investigators

  • Safaa Mahran, proff · World Health Organization

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-09-30
Primary Completion
2027-09-30
Completion
2027-10-31

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07105566 on ClinicalTrials.gov